|
Marché Fermé -
Nasdaq
22:00:00 24/07/2026
|
Varia. 5j.
|
Varia. 1 janv.
|
|
35,04 USD
|
+6,18%
|
|
+0,26%
|
-11,43%
|
|
23/07 |
AtriCure Q2 Swings to Adjusted Earnings, Revenue Rises
| | |
23/07 |
(ATRC) AtriCure Expects 2026 Adjusted EPS Range $0.24-$0.32, vs. FactSet Est of $0.12
| | |
23/07 |
(ATRC) AtriCure Expects 2026 Revenue Range $602M-$610M, vs. FactSet Est of $604.6M
| | |
23/07 |
AtriCure: Q2 Earnings Snapshot
| | |
23/07 |
Earnings Flash (ATRC) AtriCure, Inc. Reports Q2 Revenue $153.6M, vs. FactSet Est of $151.8M
| | |
23/07 |
Earnings Flash (ATRC) AtriCure, Inc. Posts Q2 Adjusted EPS $0.18 per Share, vs. FactSet Est of $0.00
| | |
23/07 |
AtriCure Reports Second Quarter 2026 Financial Results
| | |
23/07 |
AtriCure, Inc. Provides Earnings Guidance for the Full Year 2026
| | |
23/07 |
AtriCure, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
| | |
02/07 |
AtriCure to Announce Second Quarter 2026 Financial Results
| | |
29/06 |
AtriCure, Inc.(NasdaqGM:ATRC) added to Russell 2000 Defensive Index
| | |
29/06 |
AtriCure, Inc.(NasdaqGM:ATRC) added to Russell 2000 Growth-Defensive Index
| | |
27/05 |
AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference
| | |
08/05 |
AtriCure : Investor Presentation Q1 2026 vF
| | |
06/05 |
AtriCure : Q1 2026 AtriCure Inc. Earnings Conference Transcript - DAH
| | |
06/05 |
AtriCure Q1 Loss Narrows, Revenue Increases; 2026 Guidance Maintained
| | |
05/05 |
Earnings Flash (ATRC) AtriCure, Inc. Reports Q1 Revenue $141.2M, vs. FactSet Est of $139.7M
| | |
05/05 |
Earnings Flash (ATRC) AtriCure, Inc. Posts Q1 Adjusted EPS $0.00 per Share, vs. FactSet Est of $-0.06
| | |
05/05 |
AtriCure Reports First Quarter 2026 Financial Results
| | |
05/05 |
AtriCure, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
| | |
28/04 |
AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference
| | |
14/04 |
AtriCure to Announce First Quarter 2026 Financial Results
| | |
24/02 |
AtriCure to Participate in the Citizens Life Sciences Conference
| | |
18/02 |
AtriCure : Q4 and Full Year 2025 Earnings Call Transcript
| | |
17/02 |
AtriCure Q4 Swings to Profit, Revenue Rises; Issues Guidance
| |
Aucun résultat pour cette recherche Sélectionnez votre édition Toutes les informations financières adaptées au niveau national |